Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial

Josh M. Jorgensen, Charles Arnold, Per Ashorn, Ulla Ashorn, David Chaima, Yin Bun Cheung, Jasmine C.C. Davis, Yue Mei Fan, Elisha Goonatilleke, Emma Kortekangas, Chiza Kumwenda, Carlito B Lebrilla, Kenneth Maleta, Sarah M. Totten, Lauren D. Wu, Kathryn G. Dewey

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Human milk oligosaccharides (HMOs) and bioactive proteins are beneficial to infant health. Recent evidence suggests that maternal nutrition may affect the amount of HMOs and proteins in breast milk; however, the effect of nutrient supplementation on HMOs and bioactive proteins has not yet been well studied. Objective: We aimed to determine whether lipid-based nutrient supplements (LNSs) affect milk bioactive protein and HMO concentrations at 6 mo postpartum in women in rural Malawi. These are secondary outcomes of a previously published randomized controlled trial. Methods: Women were randomly assigned to consume either an iron and folic acid capsule (IFA) daily from #20 wk gestation until delivery, followed by placebo daily from delivery to 6 mo postpartum, or amultiplemicronutrient (MMN) capsule or LNS daily from ≤20 wk gestation to 6 mo postpartum. Breast milk concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, immunoglobulin A, and osteopontin were analyzed at 6 mo postpartum (n = 647). Between-group differences in concentrations and in proportions of women classified as having low concentrations were tested. Results: HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons). At 6 mo postpartum, the proportions of women with low HMOs or bioactive proteins were not different between groups except for osteopontin. A lower proportion of women in the IFA group had low osteopontin compared with the LNS group after adjusting for covariates (OR: 0.5; 95% CI: 0.3, 0.9; P = 0.016). Conclusion: The study findings do not support the hypothesis that supplementation with an LNS or MMN capsule during pregnancy and postpartum would increase HMO or bioactive milk proteins at 6 mo postpartum among Malawian women. This trial was registered at clinicaltrials.gov as NCT01239693.

Original languageEnglish (US)
Pages (from-to)1867-1874
Number of pages8
JournalJournal of Nutrition
Volume147
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Human Milk
Oligosaccharides
Lactation
Lipids
Food
Pregnancy
Postpartum Period
Proteins
Osteopontin
Capsules
Milk Proteins
Folic Acid
Iron
Malawi
Lactalbumin
Lactoferrin
Muramidase
Immunoglobulin A
Randomized Controlled Trials
Placebos

Keywords

  • Bioactive breast milk proteins
  • Human milk oligosaccharides
  • Lactation
  • Lipid-based nutrient supplements
  • Multiple micronutrient supplements
  • Postpartum

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial. / Jorgensen, Josh M.; Arnold, Charles; Ashorn, Per; Ashorn, Ulla; Chaima, David; Cheung, Yin Bun; Davis, Jasmine C.C.; Fan, Yue Mei; Goonatilleke, Elisha; Kortekangas, Emma; Kumwenda, Chiza; Lebrilla, Carlito B; Maleta, Kenneth; Totten, Sarah M.; Wu, Lauren D.; Dewey, Kathryn G.

In: Journal of Nutrition, Vol. 147, No. 10, 01.10.2017, p. 1867-1874.

Research output: Contribution to journalArticle

Jorgensen, JM, Arnold, C, Ashorn, P, Ashorn, U, Chaima, D, Cheung, YB, Davis, JCC, Fan, YM, Goonatilleke, E, Kortekangas, E, Kumwenda, C, Lebrilla, CB, Maleta, K, Totten, SM, Wu, LD & Dewey, KG 2017, 'Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial', Journal of Nutrition, vol. 147, no. 10, pp. 1867-1874. https://doi.org/10.3945/jn.117.252981
Jorgensen, Josh M. ; Arnold, Charles ; Ashorn, Per ; Ashorn, Ulla ; Chaima, David ; Cheung, Yin Bun ; Davis, Jasmine C.C. ; Fan, Yue Mei ; Goonatilleke, Elisha ; Kortekangas, Emma ; Kumwenda, Chiza ; Lebrilla, Carlito B ; Maleta, Kenneth ; Totten, Sarah M. ; Wu, Lauren D. ; Dewey, Kathryn G. / Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial. In: Journal of Nutrition. 2017 ; Vol. 147, No. 10. pp. 1867-1874.
@article{b693e89e3ca14b05b4ae9426a81d847b,
title = "Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial",
abstract = "Background: Human milk oligosaccharides (HMOs) and bioactive proteins are beneficial to infant health. Recent evidence suggests that maternal nutrition may affect the amount of HMOs and proteins in breast milk; however, the effect of nutrient supplementation on HMOs and bioactive proteins has not yet been well studied. Objective: We aimed to determine whether lipid-based nutrient supplements (LNSs) affect milk bioactive protein and HMO concentrations at 6 mo postpartum in women in rural Malawi. These are secondary outcomes of a previously published randomized controlled trial. Methods: Women were randomly assigned to consume either an iron and folic acid capsule (IFA) daily from #20 wk gestation until delivery, followed by placebo daily from delivery to 6 mo postpartum, or amultiplemicronutrient (MMN) capsule or LNS daily from ≤20 wk gestation to 6 mo postpartum. Breast milk concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, immunoglobulin A, and osteopontin were analyzed at 6 mo postpartum (n = 647). Between-group differences in concentrations and in proportions of women classified as having low concentrations were tested. Results: HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons). At 6 mo postpartum, the proportions of women with low HMOs or bioactive proteins were not different between groups except for osteopontin. A lower proportion of women in the IFA group had low osteopontin compared with the LNS group after adjusting for covariates (OR: 0.5; 95{\%} CI: 0.3, 0.9; P = 0.016). Conclusion: The study findings do not support the hypothesis that supplementation with an LNS or MMN capsule during pregnancy and postpartum would increase HMO or bioactive milk proteins at 6 mo postpartum among Malawian women. This trial was registered at clinicaltrials.gov as NCT01239693.",
keywords = "Bioactive breast milk proteins, Human milk oligosaccharides, Lactation, Lipid-based nutrient supplements, Multiple micronutrient supplements, Postpartum",
author = "Jorgensen, {Josh M.} and Charles Arnold and Per Ashorn and Ulla Ashorn and David Chaima and Cheung, {Yin Bun} and Davis, {Jasmine C.C.} and Fan, {Yue Mei} and Elisha Goonatilleke and Emma Kortekangas and Chiza Kumwenda and Lebrilla, {Carlito B} and Kenneth Maleta and Totten, {Sarah M.} and Wu, {Lauren D.} and Dewey, {Kathryn G.}",
year = "2017",
month = "10",
day = "1",
doi = "10.3945/jn.117.252981",
language = "English (US)",
volume = "147",
pages = "1867--1874",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "10",

}

TY - JOUR

T1 - Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial

AU - Jorgensen, Josh M.

AU - Arnold, Charles

AU - Ashorn, Per

AU - Ashorn, Ulla

AU - Chaima, David

AU - Cheung, Yin Bun

AU - Davis, Jasmine C.C.

AU - Fan, Yue Mei

AU - Goonatilleke, Elisha

AU - Kortekangas, Emma

AU - Kumwenda, Chiza

AU - Lebrilla, Carlito B

AU - Maleta, Kenneth

AU - Totten, Sarah M.

AU - Wu, Lauren D.

AU - Dewey, Kathryn G.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: Human milk oligosaccharides (HMOs) and bioactive proteins are beneficial to infant health. Recent evidence suggests that maternal nutrition may affect the amount of HMOs and proteins in breast milk; however, the effect of nutrient supplementation on HMOs and bioactive proteins has not yet been well studied. Objective: We aimed to determine whether lipid-based nutrient supplements (LNSs) affect milk bioactive protein and HMO concentrations at 6 mo postpartum in women in rural Malawi. These are secondary outcomes of a previously published randomized controlled trial. Methods: Women were randomly assigned to consume either an iron and folic acid capsule (IFA) daily from #20 wk gestation until delivery, followed by placebo daily from delivery to 6 mo postpartum, or amultiplemicronutrient (MMN) capsule or LNS daily from ≤20 wk gestation to 6 mo postpartum. Breast milk concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, immunoglobulin A, and osteopontin were analyzed at 6 mo postpartum (n = 647). Between-group differences in concentrations and in proportions of women classified as having low concentrations were tested. Results: HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons). At 6 mo postpartum, the proportions of women with low HMOs or bioactive proteins were not different between groups except for osteopontin. A lower proportion of women in the IFA group had low osteopontin compared with the LNS group after adjusting for covariates (OR: 0.5; 95% CI: 0.3, 0.9; P = 0.016). Conclusion: The study findings do not support the hypothesis that supplementation with an LNS or MMN capsule during pregnancy and postpartum would increase HMO or bioactive milk proteins at 6 mo postpartum among Malawian women. This trial was registered at clinicaltrials.gov as NCT01239693.

AB - Background: Human milk oligosaccharides (HMOs) and bioactive proteins are beneficial to infant health. Recent evidence suggests that maternal nutrition may affect the amount of HMOs and proteins in breast milk; however, the effect of nutrient supplementation on HMOs and bioactive proteins has not yet been well studied. Objective: We aimed to determine whether lipid-based nutrient supplements (LNSs) affect milk bioactive protein and HMO concentrations at 6 mo postpartum in women in rural Malawi. These are secondary outcomes of a previously published randomized controlled trial. Methods: Women were randomly assigned to consume either an iron and folic acid capsule (IFA) daily from #20 wk gestation until delivery, followed by placebo daily from delivery to 6 mo postpartum, or amultiplemicronutrient (MMN) capsule or LNS daily from ≤20 wk gestation to 6 mo postpartum. Breast milk concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, immunoglobulin A, and osteopontin were analyzed at 6 mo postpartum (n = 647). Between-group differences in concentrations and in proportions of women classified as having low concentrations were tested. Results: HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons). At 6 mo postpartum, the proportions of women with low HMOs or bioactive proteins were not different between groups except for osteopontin. A lower proportion of women in the IFA group had low osteopontin compared with the LNS group after adjusting for covariates (OR: 0.5; 95% CI: 0.3, 0.9; P = 0.016). Conclusion: The study findings do not support the hypothesis that supplementation with an LNS or MMN capsule during pregnancy and postpartum would increase HMO or bioactive milk proteins at 6 mo postpartum among Malawian women. This trial was registered at clinicaltrials.gov as NCT01239693.

KW - Bioactive breast milk proteins

KW - Human milk oligosaccharides

KW - Lactation

KW - Lipid-based nutrient supplements

KW - Multiple micronutrient supplements

KW - Postpartum

UR - http://www.scopus.com/inward/record.url?scp=85030535140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030535140&partnerID=8YFLogxK

U2 - 10.3945/jn.117.252981

DO - 10.3945/jn.117.252981

M3 - Article

AN - SCOPUS:85030535140

VL - 147

SP - 1867

EP - 1874

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 10

ER -